New hope for newborns: could a different drug save more babies during CPR?
NCT ID NCT05738148
First seen Jan 09, 2026 · Last updated May 23, 2026 · Updated 22 times
Summary
This study tests whether vasopressin works better than the standard drug epinephrine for newborns whose hearts have stopped or are beating too slowly. About 8 babies will receive one of the two drugs during CPR in the delivery room. The goal is to see which drug helps the heart start beating again faster and with fewer complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC ARREST NEONATAL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Royal Alexandra Hospital
Edmonton, Alberta, T5H 3V9, Canada
Conditions
Explore the condition pages connected to this study.